{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:16:15Z","timestamp":1788498975173,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010903","name":"Key Programme","doi-asserted-by":"publisher","award":["202001BB0500080"],"award-info":[{"award-number":["202001BB0500080"]}],"id":[{"id":"10.13039\/501100010903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160516"],"award-info":[{"award-number":["82160516"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007471","name":"Applied Basic Research Foundation of Yunnan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007471","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.cbi.2026.112302","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:39:09Z","timestamp":1786635549000},"page":"112302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["ADRB2 modulates asbestos-induced pleural mesothelioma progression by influencing IL-17\/NF-\u03baB-related inflammatory signalling: An integrated network toxicology, multi-omics and experimental study"],"prefix":"10.1016","volume":"438","author":[{"given":"Shaoyang","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangsheng","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jundong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8324-3686","authenticated-orcid":false,"given":"Wei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2026.112302_bib1","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/1878-0261.13591","article-title":"Pleural mesothelioma (PMe): the evolving molecular knowledge of a rare and aggressive cancer","volume":"18","author":"Rigon","year":"2024","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.cbi.2026.112302_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/1759-7714.70259","article-title":"Emerging strategies in the diagnosis and treatment of pleural mesothelioma: an overview","volume":"17","author":"Pagliaro","year":"2026","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.cbi.2026.112302_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2026.103720","article-title":"Update on pleural epithelioid mesothelioma: new insights for diagnosis and patient management","author":"Salle","year":"2026","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.cbi.2026.112302_bib4","first-page":"1078","article-title":"Potential treatment approaches for malignant peritoneal mesothelioma: in vivo and in vitro experimental study of natural killer cell immunotherapy","volume":"21","author":"Wu","year":"2024","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.cbi.2026.112302_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1388829","article-title":"Case report: complete response and long-term survival on third-line immunotherapy in patient with pleural mesothelioma","volume":"14","author":"Juric Culjak","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cbi.2026.112302_bib6","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.21037\/jtd-20-2761","article-title":"Epidemiology, diagnosis and treatment of the malignant pleural mesothelioma, a narrative review of literature","volume":"13","author":"Schumann","year":"2021","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.cbi.2026.112302_bib7","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1111\/cas.14001","article-title":"In commemoration of the 2018 mataro nagayo prize: a road to early diagnosis and monitoring of asbestos-related mesothelioma","volume":"110","author":"Hino","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.cbi.2026.112302_bib8","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jtho.2021.12.014","article-title":"The 2021 WHO classification of Tumors of the Pleura: advances since the 2015 classification","volume":"17","author":"Sauter","year":"2022","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.cbi.2026.112302_bib9","first-page":"18","article-title":"Diagnostic challenges in Pleural mesothelioma","author":"Lapidot","year":"2026","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cbi.2026.112302_bib10","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/ajco.13455","article-title":"Bevacizumab plus cisplatin\/pemetrexed then bevacizumab alone for unresectable malignant pleural mesothelioma: a Japanese safety study","volume":"17","author":"Nakano","year":"2021","journal-title":"Asia Pac. J. Clin. Oncol."},{"key":"10.1016\/j.cbi.2026.112302_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13195837","article-title":"Malignant pleural mesothelioma: a comprehensive review","volume":"13","author":"Jain","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cbi.2026.112302_bib12","doi-asserted-by":"crossref","DOI":"10.1057\/s41271-026-00632-x","article-title":"Still killing millions by asbestos: global leadership and the urgent roadmap for actions","author":"Aryal","year":"2026","journal-title":"J. Publ. Health Pol."},{"key":"10.1016\/j.cbi.2026.112302_bib13","doi-asserted-by":"crossref","first-page":"22328","DOI":"10.1007\/s11356-017-9403-9","article-title":"Chrysotile and rock wool fibers induce chromosome aberrations and DNA damage in V79 lung fibroblast cells","volume":"25","author":"Cui","year":"2018","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"10.1016\/j.cbi.2026.112302_bib14","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/thx.35.8.564","article-title":"Pleural calcification, pleural mesotheliomas, and bronchial cancers caused by tremolite dust","volume":"35","author":"Yazicioglu","year":"1980","journal-title":"Thorax"},{"key":"10.1016\/j.cbi.2026.112302_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/carcin\/bgag030","article-title":"Asbestos exposure induces malignant - like phenotypes via minority MOMP and displays characteristics of drug-tolerant persister cells","author":"Aggison","year":"2026","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cbi.2026.112302_bib16","doi-asserted-by":"crossref","DOI":"10.1177\/17588359211061956","article-title":"Immunotherapy, the promise for present and future of malignant pleural mesothelioma (MPM) treatment","volume":"13","author":"Gounant","year":"2021","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.cbi.2026.112302_bib17","first-page":"36","article-title":"Pleural malignant mesothelioma, genetic susceptibility and asbestos exposure","volume":"592","author":"Neri","year":"2005","journal-title":"Mutat. Res."},{"key":"10.1016\/j.cbi.2026.112302_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231710085","article-title":"Synthetic secoisolariciresinol diglucoside (LGM2605) prevents asbestos-induced inflammation and genotoxic cell damage in human mesothelial cells","volume":"23","author":"Pietrofesa","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2026.112302_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2025.108893","article-title":"Multi-omic screening for pleural mesothelioma in asbestos-exposed populations: a literature review and recommendations","volume":"212","author":"Zwijsen","year":"2026","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cbi.2026.112302_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2026.109427","article-title":"Epidermal growth factor receptor-targeted near-infrared photoimmunotherapy for malignant pleural mesothelioma","volume":"217","author":"Kano","year":"2026","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cbi.2026.112302_bib21","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1158\/1078-0432.CCR-11-2259","article-title":"Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma","volume":"18","author":"Carbone","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cbi.2026.112302_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12989-023-00522-0","article-title":"An investigation of the internal morphology of asbestos ferruginous bodies: constraining their role in the onset of malignant mesothelioma","volume":"20","author":"Avramescu","year":"2023","journal-title":"Part. Fibre Toxicol."},{"key":"10.1016\/j.cbi.2026.112302_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/antiox15010121","article-title":"Reactive oxygen species drive cell migration and PD-L1 expression via YB-1 phosphorylation in pleural mesothelioma","volume":"15","author":"Hashim","year":"2026","journal-title":"Antioxidants"},{"key":"10.1016\/j.cbi.2026.112302_bib24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-025-00640-3","article-title":"Pleural mesothelioma","volume":"11","author":"Fennell","year":"2025","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.cbi.2026.112302_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7249912","article-title":"Sera from patients with malignant pleural mesothelioma tested positive for IgG antibodies against SV40 large T antigen: the viral oncoprotein","volume":"2022","author":"Mazzoni","year":"2022","journal-title":"J. Oncol."},{"key":"10.1016\/j.cbi.2026.112302_bib26","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1053\/j.semnuclmed.2025.01.003","article-title":"Current status of staging and restaging malignant pleural mesothelioma","volume":"55","author":"Lopci","year":"2025","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.cbi.2026.112302_bib27","doi-asserted-by":"crossref","DOI":"10.21037\/pcm-21-12","article-title":"Asbestos-induced chronic inflammation in malignant pleural mesothelioma and related therapeutic approaches-a narrative review","volume":"4","author":"Zolondick","year":"2021","journal-title":"Precis Cancer Med"},{"key":"10.1016\/j.cbi.2026.112302_bib28","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1470-2045(24)00155-4","article-title":"EPA ruling to ban chrysotile asbestos","volume":"25","author":"Burki","year":"2024","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.cbi.2026.112302_bib29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.coi.2020.04.005","article-title":"Mesothelial cells regulate immune responses in health and disease: role for immunotherapy in malignant mesothelioma","volume":"64","author":"Mutsaers","year":"2020","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cbi.2026.112302_bib30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.canlet.2012.02.034","article-title":"Immunity and malignant mesothelioma: from mesothelial cell damage to tumor development and immune response-based therapies","volume":"322","author":"Izzi","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cbi.2026.112302_bib31","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1007\/s11033-021-06250-y","article-title":"The role of ADRB2 gene polymorphisms in malignancies","volume":"48","author":"Wang","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.cbi.2026.112302_bib32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jid.2021.05.031","article-title":"Defining a role for G-Protein coupled Receptor\/cAMP\/CRE-Binding protein signaling in hair follicle stem cell activation","volume":"142","author":"Miranda","year":"2022","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cbi.2026.112302_bib33","article-title":"ADRB2 is regulated by TRIM22 and facilitates lung adenocarcinoma progression via JAK2\/STAT3 signaling pathway","volume":"15","author":"Xu","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2026.112302_bib34","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1016\/j.ymthe.2024.08.028","article-title":"Intrinsic ADRB2 inhibition improves CAR-T cell therapy efficacy against prostate cancer","volume":"32","author":"Ajmal","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.cbi.2026.112302_bib35","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.21037\/tcr-21-1257","article-title":"ADRB2 is a potential protective gene in breast cancer by regulating tumor immune microenvironment","volume":"10","author":"Wei","year":"2021","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.cbi.2026.112302_bib36","first-page":"283","article-title":"Amphibole, but not chrysotile, asbestos induces anti-nuclear autoantibodies and IL-17 in C57BL\/6 mice","volume":"11","author":"Ferro","year":"2014","journal-title":"J. Immunot."},{"key":"10.1016\/j.cbi.2026.112302_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911248","article-title":"Antagonist of growth hormone-releasing hormone potentiates the antitumor effect of pemetrexed and cisplatin in pleural mesothelioma","volume":"23","author":"Gesmundo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2026.112302_bib38","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/10408444.2023.2283169","article-title":"An updated evaluation of reported no-observed adverse effect levels for chrysotile, amosite, and crocidolite asbestos for lung cancer and mesothelioma","volume":"53","author":"Beckett","year":"2023","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.cbi.2026.112302_bib39","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s40001-025-03688-9","article-title":"A chemokine-based prognostic model featuring CXCL8, ITGA5, BACE2, CCR7, CERS4, and MEI1 for cervical cancer","volume":"31","author":"Wang","year":"2025","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.cbi.2026.112302_bib40","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s12079-022-00686-y","article-title":"A comprehensive network map of IL-17A signaling pathway","volume":"17","author":"Rex","year":"2023","journal-title":"J. Cell Commun. Signal."},{"key":"10.1016\/j.cbi.2026.112302_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110757","article-title":"IL-17A functions and the therapeutic use of IL-17A and IL-17RA targeted antibodies for cancer treatment","volume":"123","author":"Song","year":"2023","journal-title":"Int. Immunopharmacol."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279726004102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279726004102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:26:48Z","timestamp":1788496008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279726004102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":41,"alternative-id":["S0009279726004102"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2026.112302","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ADRB2 modulates asbestos-induced pleural mesothelioma progression by influencing IL-17\/NF-\u03baB-related inflammatory signalling: An integrated network toxicology, multi-omics and experimental study","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2026.112302","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112302"}}